• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰胆碱酯酶抑制剂:专利研究综述(2008 年至今)。

Acetylcholinesterase inhibitors: a patent review (2008 - present).

机构信息

University of Defense, Faculty of Military Health Sciences, Trebesska 1575, 50001 Hradec Kralove, Czech Republic.

出版信息

Expert Opin Ther Pat. 2012 Aug;22(8):871-86. doi: 10.1517/13543776.2012.701620. Epub 2012 Jul 6.

DOI:10.1517/13543776.2012.701620
PMID:22768972
Abstract

INTRODUCTION

Both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are present in the body in large amounts. AChE is an important part of the cholinergic nervous system taking place in the central and peripheral nervous system. AChE is a target of several toxins such as insecticide carbofuran, nerve agents, sarin, soman, tabun and VX. Beside toxins, drugs for treatment of Alzheimer's disease and myasthenia gravis, such as galantamine, donepezil, rivastigmine, tacrine, huperzine, pyridostigmine and neostigmine, are known.

AREAS COVERED

The review gives an overview of the importance of the cholinergic nervous system, the biochemistry of AChE and the role of AChE inhibitors. Current efforts to introduce potent drugs for Alzheimer's disease therapy and reduce toxicity, while keeping the maximal pharmacological effect, are also discussed.

EXPERT OPINION

The current research effort into AChE inhibitors can be divided into two categories. First, new toxins useful for agricultural purposes and second, novel drugs that need to be prepared, although there is less interest in the new toxins. The research for drugs for Alzheimer's disease needs to focus on inhibitors that reduce the deposition of amyloid plaques, but do not initiate AChE expression.

摘要

简介

乙酰胆碱酯酶(AChE)和丁酰胆碱酯酶(BChE)在体内大量存在。AChE 是胆碱能神经系统的重要组成部分,存在于中枢和周围神经系统中。AChE 是几种毒素的靶标,如杀虫剂呋喃丹、神经毒剂沙林、梭曼、塔崩和 VX。除了毒素,用于治疗阿尔茨海默病和重症肌无力的药物,如加兰他敏、多奈哌齐、利斯的明、他克林、石杉碱甲、吡斯的明和新斯的明,也是已知的。

涵盖领域

综述概述了胆碱能神经系统的重要性、AChE 的生物化学以及 AChE 抑制剂的作用。还讨论了目前为引入治疗阿尔茨海默病的有效药物和降低毒性而同时保持最大药理作用所做的努力。

专家意见

目前对 AChE 抑制剂的研究可分为两类。第一类是用于农业目的的新型毒素,第二类是需要制备的新型药物,尽管对新型毒素的兴趣较小。用于治疗阿尔茨海默病的药物研究需要集中于能减少淀粉样斑块沉积而不引发 AChE 表达的抑制剂。

相似文献

1
Acetylcholinesterase inhibitors: a patent review (2008 - present).乙酰胆碱酯酶抑制剂:专利研究综述(2008 年至今)。
Expert Opin Ther Pat. 2012 Aug;22(8):871-86. doi: 10.1517/13543776.2012.701620. Epub 2012 Jul 6.
2
Cholinesterase inhibitors: a patent review (2007 - 2011).胆碱酯酶抑制剂:专利研究综述(2007-2011)。
Expert Opin Ther Pat. 2012 Aug;22(8):853-69. doi: 10.1517/13543776.2012.701619. Epub 2012 Jul 6.
3
Recent advances in acetylcholinesterase Inhibitors and Reactivators: an update on the patent literature (2012-2015).近年来乙酰胆碱酯酶抑制剂和重活化剂的研究进展:专利文献更新(2012-2015 年)。
Expert Opin Ther Pat. 2017 Apr;27(4):455-476. doi: 10.1080/13543776.2017.1272571. Epub 2017 Jan 17.
4
Sensitivity of butyrylcholinesterase knockout mice to (--)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission.丁酰胆碱酯酶基因敲除小鼠对(-)-石杉碱甲和多奈哌齐的敏感性表明,丁酰胆碱酯酶缺乏的人可能无法耐受这些治疗阿尔茨海默病的药物,并提示丁酰胆碱酯酶在神经传递中的作用。
Toxicology. 2007 Apr 20;233(1-3):60-9. doi: 10.1016/j.tox.2006.11.069. Epub 2006 Dec 2.
5
Acetylcholinesterase inhibitors as Alzheimer therapy: from nerve toxins to neuroprotection.乙酰胆碱酯酶抑制剂作为阿尔茨海默病治疗药物:从神经毒素到神经保护。
Eur J Med Chem. 2013;70:165-88. doi: 10.1016/j.ejmech.2013.09.050. Epub 2013 Oct 6.
6
Cholinesterases, a target of pharmacology and toxicology.胆碱酯酶,药理学和毒理学的一个靶点。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2011 Sep;155(3):219-29. doi: 10.5507/bp.2011.036.
7
Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.口服溴吡斯的明和石杉碱甲可保护人体全血胆碱酯酶在体外免受梭曼暴露的影响。
Chem Biol Interact. 2005 Dec 15;157-158:239-46. doi: 10.1016/j.cbi.2005.10.031. Epub 2005 Oct 26.
8
Molecular modeling, docking and ADMET studies applied to the design of a novel hybrid for treatment of Alzheimer's disease.分子建模、对接及ADMET研究应用于一种治疗阿尔茨海默病新型杂合物的设计。
J Mol Graph Model. 2006 Oct;25(2):169-75. doi: 10.1016/j.jmgm.2005.12.002. Epub 2006 Jan 18.
9
A review on cholinesterase inhibitors for Alzheimer's disease.关于阿尔茨海默病的胆碱酯酶抑制剂的综述。
Arch Pharm Res. 2013 Apr;36(4):375-99. doi: 10.1007/s12272-013-0036-3. Epub 2013 Feb 24.
10
Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease.新型他克林类似物作为阿尔茨海默病潜在的胆碱酯酶抑制剂。
Arch Pharm (Weinheim). 2014 Feb;347(2):96-103. doi: 10.1002/ardp.201300121. Epub 2013 Dec 16.

引用本文的文献

1
Exploring Novel Quinoline-1,3,4-Oxadiazole Derivatives for Alzheimer's Disease: Their Design, Synthesis, and In-Vitro and In-Silico Investigations.探索用于阿尔茨海默病的新型喹啉-1,3,4-恶二唑衍生物:它们的设计、合成以及体外和计算机模拟研究。
Curr Med Chem. 2024 Aug 28. doi: 10.2174/0109298673333159240815061359.
2
Innovative Therapeutic Strategies in Alzheimer's Disease: A Synergistic Approach to Neurodegenerative Disorders.阿尔茨海默病的创新治疗策略:神经退行性疾病的协同治疗方法
Pharmaceuticals (Basel). 2024 Jun 6;17(6):741. doi: 10.3390/ph17060741.
3
Labdanum Resin from L. as a Source of Compounds with Anti-Diabetic, Neuroprotective and Anti-Proliferative Activity.
没药树脂从 L. 作为具有抗糖尿病、神经保护和抗增殖活性的化合物的来源。
Molecules. 2024 May 9;29(10):2222. doi: 10.3390/molecules29102222.
4
Development of scoring-assisted generative exploration (SAGE) and its application to dual inhibitor design for acetylcholinesterase and monoamine oxidase B.评分辅助生成性探索(SAGE)的开发及其在乙酰胆碱酯酶和单胺氧化酶B双重抑制剂设计中的应用。
J Cheminform. 2024 May 24;16(1):59. doi: 10.1186/s13321-024-00845-w.
5
Citronellal as a Promising Candidate for Alzheimer's Disease Treatment: A Comprehensive Study on In Silico and In Vivo Anti-Acetylcholine Esterase Activity.香茅醛作为阿尔茨海默病治疗的潜在候选药物:关于计算机模拟和体内抗乙酰胆碱酯酶活性的综合研究
Metabolites. 2023 Nov 4;13(11):1133. doi: 10.3390/metabo13111133.
6
New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength.新斯的明临床应用的新进展:不再仅仅专注于增强骨骼肌力量。
Front Pharmacol. 2023 Aug 4;14:1227496. doi: 10.3389/fphar.2023.1227496. eCollection 2023.
7
Identification of potential inhibitors against Alzheimer-related proteins in ethanol extract: experimental evidence and computational analyses.乙醇提取物中阿尔茨海默病相关蛋白潜在抑制剂的鉴定:实验证据与计算分析
3 Biotech. 2023 Sep;13(9):292. doi: 10.1007/s13205-023-03714-9. Epub 2023 Aug 4.
8
Neurotoxicity Assessment of Four Different Pesticides Using In Vitro Enzymatic Inhibition Assays.使用体外酶抑制试验对四种不同农药进行神经毒性评估
Toxics. 2022 Aug 3;10(8):448. doi: 10.3390/toxics10080448.
9
Electrochemical Biosensor for Markers of Neurological Esterase Inhibition.用于神经酯酶抑制标志物的电化学生物传感器。
Biosensors (Basel). 2021 Nov 16;11(11):459. doi: 10.3390/bios11110459.
10
Effects of Natural Products on Neuromuscular Junction.天然产物对神经肌肉接头的影响。
Curr Neuropharmacol. 2022 Mar 4;20(3):594-610. doi: 10.2174/1570159X19666210924092627.